跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 781 条关于
“MA-4604”
全部
781
临床试验
158
药物
142
机构
337
资讯
144
去年
Maipl Therapeutics and Endosure Form Alliance to Accelerate Non-Hormonal Endometriosis Treatment Development
去年
First Oral Drug MA-5 Shows Promise for Rare Barth Syndrome in Preclinical Studies
去年
Chelsea, MA Launches Citywide Mental Health Campaign for Youth Wellbeing
去年
EMPA-KIDNEY Trial: Empagliflozin Shows Sustained Cardiorenal Benefits in CKD Patients Post-Discontinuation
去年
MapLight Therapeutics Initiates Phase 2 Trial of Novel M1/M4 Muscarinic Agonist ML-007C-MA for Schizophrenia Treatment
去年
RLY-2608 Plus Fulvestrant Shows Promise in PI3Kα-Mutated, HR+/HER2- Breast Cancer
8个月前
MapLight Therapeutics Receives FDA Fast Track Designation for Alzheimer's Disease Psychosis Treatment
去年
Darolutamide Falls Short in Phase II Trial for AR-Positive Triple-Negative Breast Cancer
2个月前
Deep Origin Secures $31.7M ARPA-H Contract to Build FDA-Qualifiable Virtual Human Platform for Drug Testing
去年
Navigating the Regulatory Landscape of Cell and Gene Therapies in the EU and UK
第 1 页,共 15 页
上一页
下一页